SME IPO Reviews NSE Emerge & BSE SME

The company trades at 0.5× sector midpoint with exceptional 130.8% PAT CAGR and 39.68% ROCE, signaling strong operational execution. High debt-to-equity of 2.54× and thin 6.3% net margins are material risks that warrant post-listing monitoring of deleveraging progress.

The company faces a severe operational crisis with revenue collapsing 73.4% over two years and PAT declining 67.5%, despite a superficially attractive 8.8x P/E. The business model has deteriorated sharply—FY0 revenue of ₹3.8 Cr against ₹53.5 Cr in FY-2 signals fundamental distress, not valuation opportunity.

The company faces a sharp revenue and profit contraction with a -5.3% revenue CAGR over two years, declining from ₹119.9 Cr (FY-1) to ₹72.2 Cr (FY0). While the P/E of 10.2x appears attractive at 0.44× sector midpoint, the deteriorating operational trajectory and negative growth momentum outweigh valuation appeal.

Despite attractive valuation at 0.58× sector midpoint and strong margins (24.9% NPM, 51.58% EBITDA), the company faces a critical operational crisis: revenue collapsed 60% and PAT fell 75% in FY0, signaling either demand destruction or execution failure that valuation alone cannot justify.

The company trades at 0.6× sector midpoint with exceptional 118% PAT CAGR and 42% ROCE, signalling strong operational efficiency. Key risk: promoter stake drops to zero post-issue, eliminating founder alignment and creating potential governance concern.

The company faces severe revenue contraction of -41.9% over two years, with FY0 revenue collapsing to ₹12.4 Cr from ₹48.6 Cr, signaling acute operational distress. While the P/E of 14.97x appears attractive at 0.65× sector midpoint, the underlying business deterioration and negative growth trajectory outweigh valuation appeal.

The company faces a severe revenue collapse of -44.4% over two years, falling from ₹27.1 Cr to ₹7.7 Cr in FY0, which signals fundamental operational distress that cannot be offset by its healthy 19.3% net margin. Post-IPO promoter dilution to 0% combined with weak ROCE of 8.27% and deteriorating scale make this a high-risk turnaround play unsuitable for retail investors.

The company trades at 0.68× sector midpoint with strong ROCE of 51.82% and a 2-year revenue CAGR of 382.5%, indicating efficient capital deployment and rapid scaling. Key risk: FY0 revenue collapsed 65% year-on-year to ₹69.8 Cr, signalling either cyclical weakness or execution challenges that warrant post-listing monitoring.

The company demonstrates strong operational momentum with PAT CAGR of 44.7% over two years and a healthy ROCE of 23.98%, supported by disciplined capital structure (D/E 0.99x). Valuation at 1.57× sector midpoint is justified by double-digit net margins and accelerating profitability, though execution risk on the new manufacturing facility remains material.

The company faces a severe revenue collapse of -49.7% over two years, falling from ₹193.2 Cr to ₹47.4 Cr in FY0, which signals fundamental business distress unrelated to valuation. While the P/E of 11.67x appears cheap at 0.25× sector midpoint, the underlying business deterioration, weak subscription (0.76x), and elevated debt (D/E 1.71x) make this a value trap rather than a bargain.